Abstract
Cross-communication between different signalling systems allows the integration of the great diversity of stimuli that a cell receives under varying physiological situations. The transactivation of epidermal growth factor receptor (EGFR)-dependent signalling pathways upon stimulation of G-protein-coupled receptors (GPCRs), which are critical for the mitogenic activity of ligands such as lysophosphatidic acid, endothelin, thrombin, bombesin and carbachol, provides evidence for such an interconnected communication network1,2,3,4. Here we show that EGFR transactivation upon GPCR stimulation involves proHB-EGF and a metalloproteinase activity that is rapidly induced upon GPCR–ligand interaction. We show that inhibition of proHB-EGF processing blocks GPCR-induced EGFR transactivation and downstream signals. The pathophysiological significance of this mechanism is demonstrated by inhibition of constitutive EGFR activity upon treatment of PC3 prostate carcinoma cells with the metalloproteinase inhibitor batimastat. Together, our results establish a new mechanistic concept for cross-communication among different signalling systems.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Daub,H., Wallasch,C., Lankenau,A., Herrlich,A. & Ullrich,A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J. 16, 7032–7044 (1997).
Daub,H., Weiss,F. U., Wallasch,C. & Ullrich,A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379, 557–560 (1996).
Luttrell,L. M., Daaka,Y. & Lefkowitz,R. J. Regulation of tyrosine cascades by G-protein-coupled receptors. Curr. Opin. Cell Biol. 11, 177–183 (1999).
Hackel,P. O., Zwick,E., Prenzel,N. & Ullrich,A. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr. Opin. Cell Biol. 11, 184–189 (1999).
Eguchi,S. et al. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J. Biol. Chem. 273, 8890–8896 (1998).
Luttrell,L. M., Della Rocca,G. J., van Biesen,T., Luttrell,E. K. & Lefkowitz,R. J. Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 272, 4637–4644 (1997).
Keely,S. J., Uribe,J. M. & Barrett,K. E. Carbachol stimulates transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T84 cells. J. Biol. Chem. 273, 27111–27117 (1998).
Tsai,W., Morielli,A. D. & Peralta,E. G. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J. 16, 4597–4605 (1997).
Li,X., Lee,J. W., Graves,L. M. & Earp,H. S. Angiotensin II stimulates ERK via two pathways in epithelial cells: protein kinase C suppresses a G-protein coupled receptor–EGF receptor transactivation pathway. EMBO J. 9, 2574–2583 (1998).
Seedorf,K., Felder,S., Millauer,B., Schlessinger,J. & Ullrich,A. Analysis of platelet-derived growth factor receptor domain function using a novel chimeric receptor approach. J. Biol. Chem. 266, 12424–12431 (1991).
Kovalenko,M. et al. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res. 54, 6106–6114 (1994).
Vogel,W., Lammers,R., Huang,J. & Ullrich,A. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science 259, 1611–1614 (1993).
Mateo, C. et al. Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity. Immunotechnology 3, 71–81 (1997).
Massagué,J. & Pandiella,A. Membrane-anchored growth factors. Annu. Rev. Biochem. 62, 515–541 (1993).
Bosenberg,M. W., Pandiella,A. & Massaqué,J. Activated release of membrane-anchored TGF-α in the absence of cytosol. J. Cell Biol. 122, 95–101 (1993).
Goishi,K. et al. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell 6, 967–980 (1995).
Dethlefsen,S. M. et al. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C. J. Cell. Biochem. 69, 143–153 (1998).
Zwick, E. et al. Critical role of calcium-dependent epidermal growth factor receptor transactivation in PC12 cells membrane depolarization and bradykinin signaling. J. Biol. Chem. 272, 24767–24770 (1997).
Raab,G. & Klagsbrun,M. Heparin-binding EGF-like growth factor. Biochim. Biophys. Acta 1333, F179–F199 (1997).
Naglich,J. G., Metherall,J. E., Russell,D. W. & Eidels,L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 69, 1051–1061 (1992).
Mitamura,T., Higashiyama,S., Taniguchi,N., Klagsbrun,M. & Mekada,E. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J. Biol. Chem. 270, 1015–1019 (1995).
Chen,Y. et al. Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor. EMBO J. 15, 1037–1044 (1996).
Izumi,Y. et al. A metalloprotease-disintegrin, MDC9/meltrin-γ/ADAM9 and PKCδ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17, 7260–7272 (1998).
Wojtowicz-Praga,S. M., Dickson,R. B. & Hawkins,M. J. Matrix metalloproteinase inhibitors. Investigational New Drugs 15, 61–75 (1997).
Ching,K. Z. et al. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol. Cell Biochem. 126, 151–158 (1993).
Hoosein,N. M., Logothetis,C. J. & Chung,L. W. K. Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J. Urol. 149, 1209–1213 (1993).
Dong,J. et al. Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. Proc. Natl Acad. Sci. USA 96, 6235–6240 (1999).
Werb,Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91, 439–442 (1997).
Schägger,H. & von Jagow,G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDA. Anal. Biochem. 166, 368–379 (1987).
Acknowledgements
We are grateful to E. Mekada for plasmids containing ADAM9-WT and proteinase-inactive mutants, and J. Bange for the pcDNA3-VSV vector. ICR-3R antibody and batimastat were generous gifts from C. Mateo and K. Maskos, respectively. We thank P. O. Hackel and K. Specht for helpful discussions and I. Sures for critically reading the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prenzel, N., Zwick, E., Daub, H. et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402, 884–888 (1999). https://doi.org/10.1038/47260
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/47260
This article is cited by
-
The role of neurotrophic factors in novel, rapid psychiatric treatments
Neuropsychopharmacology (2024)
-
Transactivation of receptor tyrosine kinases by purinergic P2Y and adenosine receptors
Purinergic Signalling (2023)
-
Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy
Cellular Oncology (2022)
-
Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload
Cell Death & Disease (2021)
-
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation
Cancer Gene Therapy (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.